Sensus Healthcare (SRTS)

• Market cap: $75.4M
• 1 day: 2.70%
• 5 days: -0.87%
• 1 month: -19.12%
• 3 months: -46.17%
• 6 months: -21.88%
• Year to date: -35.63%
• 1 year: 28.73%
• 5 years: 44.62%
• 10 years: -21.88%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Employees: 54

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,600% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 1

1,068% more call options, than puts

Call options by funds: $222K | Put options by funds: $19K

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

50% more capital invested

Capital invested by funds: $22.6M [Q3] → $33.9M (+$11.3M) [Q4]

30% more funds holding

Funds holding: 50 [Q3] → 65 (+15) [Q4]

6.21% more ownership

Funds ownership: 23.71% [Q3] → 29.92% (+6.21%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 163% upside
• Avg. target: $12.50 174% upside
• High target: $13 184% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Lake Street Ben Haynor 50% 1-year accuracy 5 / 10 met price target	184% upside $13	Buy Maintained	11 Mar 2025
HC Wainwright & Co. Yi Chen 38% 1-year accuracy 62 / 162 met price target	163% upside $12	Buy Maintained	10 Feb 2025